Q-MED LAUNCHES A PHARMACEUTICAL IN SWEDEN

A A

Q-Med announces that a pharmaceutical, Cosmofer (low molecular iron dextran), has now been approved for sales in Sweden. It is estimated that sales will start towards the end of the year. Q-Med has an agreement with the Danish manufacturer Nebo/Pharmacosmos concerning sales rights for the preparation on the Swedish market. PipelineReview (http://www.pipelinereview.com/joomla/content/view/5148/126/)